TEVA - GSK to buy Aiolos Bio for up to $1.4B to expand respiratory portfolio January, 09 2024 04:33 AM Teva Pharmaceutical Industries Limited American Depositary Shares 2024-01-09 04:33:26 ET More on GSK GSK - Greenshoots In The Horizon Getting_Ahead_of_Respiratory_Diseases_Slides GSK, Teva, AstraZeneca under Senate probe over asthma inhaler pricing For further details see: GSK to buy Aiolos Bio for up to $1.4B to expand respiratory portfolio